1194375-40-0

Basic information

• Product Name: 7-bromo-2-methylimidazo[1,2-a]pyridine
• Synonyms: 7-bromo-2-methylimidazo[1,2-a]pyridine;IMidazo[1,2-a]pyridine, 7-broMo-2-Methyl-
• CAS NO: 1194375-40-0
• Molecular Formula: C₈H₇BrN₂
• Molecular Weight: 211.05858
• Mol File: 1194375-40-0.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 7-bromo-2-methylimidazo[1,2-a]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 7-bromo-2-methylimidazo[1,2-a]pyridine(1194375-40-0)
• EPA Substance Registry System: 7-bromo-2-methylimidazo[1,2-a]pyridine(1194375-40-0)

Safety Data

• Hazardous Substances Data: 1194375-40-0(Hazardous Substances Data)

Usage

General Description

7-bromo-2-methylimidazo[1,2-a]pyridine is a chemical compound with the molecular formula C8H7BrN2. It is a heterocyclic aromatic compound containing a bromine atom and a methyl group. This chemical is a known mutagen and is classified as a Group 2B carcinogen by the International Agency for Research on Cancer. It is commonly found as a contaminant in grilled and smoked foods, particularly meats cooked at high temperatures. Exposure to 7-bromo-2-methylimidazo[1,2-a]pyridine has been linked to an increased risk of cancer, particularly in the colon and prostate. Thus, efforts are being made to reduce levels of this chemical in food and to develop safer cooking methods to minimize human exposure.

Upstream product

• 84249-14-9 2-amino-4-bromopyridine 
• 126-38-5 1-bromo-2,2-dimethoxypropane 

Downstream Products

• 1375110-97-6 2-methylimidazo[1,2-a]pyridin-7-amine 

Relevant articles and documents

Heterocyclic kinase inhibitor

The invention belongs to the technical field of medicines, and particularly relates to a heterocyclic DNA-PK kinase inhibitor compound shown as a general formula (I), a pharmaceutically acceptable salt and an isomer thereof, a pharmaceutical composition and preparation containing the compound, the pharmaceutically acceptable salt and the isomer thereof, a method for preparing the compound, the pharmaceutically acceptable salt and the isomer thereof, and application of the compound, the pharmaceutically acceptable salt and the isomer thereof.

Substituted heteroaryl compounds and compositions and uses thereof (by machine translation)

The invention discloses substituted heteroaryl compounds and compositions thereof and their use. The compounds of formula (I) compound or type shown in (I) a compound represented by stereo isomers, tautomers, nitrogen oxide, solvate, metabolite, pharmaceutically acceptable salt or its prodrug. The invention also provides a pharmaceutical composition, the compounds and pharmaceutical compositions can be regulated protein kinase, particularly Aurora kinase and JAK kinase activity, for the prevention, treatment, treatment and reduce protein kinase, in particular JAK kinase activity mediated diseases or disorders. (by machine translation)